Could N-acetylcysteine benefit patients with SUDs?
Closer tailoring might boost wearable cardioverter defibrillators’ benefit, alirocumab cuts deaths in post–acute coronary syndrome patients, the ODYSSEY Outcomes trial redefines secondary cardiovascular prevention, and how walking cuts postmenopausal women’s heart failure risk.
Listen to the MDedge Daily News podcast for all the details on today’s top news.
We noticed you have an ad blocker enabled. Please whitelist us so we can continue to provide free content.